FDx Advisors’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-11,545
Closed -$1.03M 1263
2017
Q1
$1.03M Sell
11,545
-11,342
-50% -$933K 0.03% 520
2016
Q4
$1.62M Sell
22,887
-540
-2% -$40.2K 0.05% 348
2016
Q3
$1.85M Buy
23,427
+626
+3% +$53.4K 0.08% 226
2016
Q2
$2.07M Sell
22,801
-1,999
-8% -$169K 0.09% 196
2016
Q1
$2.11M Sell
24,800
-4,876
-16% -$363K 0.1% 189
2015
Q4
$2.34M Buy
29,676
+5,622
+23% +$443K 0.11% 161
2015
Q3
$1.69M Sell
24,054
-4,305
-15% -$354K 0.15% 139
2015
Q2
$2.56M Buy
28,359
+1,159
+4% +$112K 0.13% 136
2015
Q1
$2.73M Sell
27,200
-328
-1% -$33.1K 0.06% 246
2014
Q4
$2.77M Sell
27,528
-5,385
-16% -$537K 0.17% 107
2014
Q3
$3.17M Buy
32,913
+5,195
+19% +$492K 0.21% 91
2014
Q2
$2.58M Buy
27,718
+3,066
+12% +$268K 0.17% 130
2014
Q1
$2.05M Buy
24,652
+14,550
+144% +$1.18M 0.17% 130
2013
Q4
$846K Buy
10,102
+6,822
+208% +$556K 0.08% 230
2013
Q3
$244K Buy
3,280
+352
+12% +$26.4K 0.03% 506
2013
Q2
$232K Buy
+2,928
New +$235K 0.03% 448

Other funds holding MJN

FDx Advisors's MJN Position: Q2 2017 in Review

FDx Advisors sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 11,545 shares — an estimated $1.03M sold.

FDx Advisors first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $3.17M in Q3 2014. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • FDx Advisors reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • FDx Advisors sold 11,545 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $1.03M.
  • FDx Advisors first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • FDx Advisors's Mead Johnson Nutrition Company position peaked at $3.17M in Q3 2014.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on FDx Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.